IP Group PLC — Remuneration Information 2022

Apr 25, 2022

National Storage Mechanism | Additional information

RNS Number : 2734J

IP Group PLC

25 April 2022

FOR RELEASE ON	# 25 APRIL 2022

IP Group plc - DBSP awards; Director/PDMR shareholding

IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which develops world-changing science and technology businesses across life sciences, technology and cleantech, announces the following in connection with its employee share schemes.

Deferred Bonus Share Plan ("DBSP") Awards

IP Group has granted nil-cost options over ordinary shares of two pence each ("Shares") to the executive directors and persons discharging managerial responsibilities ("PDMRs") under the Group's DBSP on 21 April 2022. The grants reflect the deferral of fifty per cent of each person's award above £25,000 under the Group's Annual Incentive Scheme ("AIS") in respect of the Group's performance for the financial year ended 31 December 2021. The following table sets out details of the awards made to the Executive Directors and PDMRs: 

Name of Director/PDMR	Structure of award	Number of options granted	Total number of options currently held
Greg Smith	Nil-Cost Option	176,200	298,403
David Baynes	Nil-Cost Option	150,902	269,013
Sam Williams	Nil-Cost Option	82,364	153,086
Mark Reilly	Nil-Cost Option	94,736	160,210
Angela Leach	Nil-Cost Option	58,224	102,758
Christopher Glasson	Nil-Cost Option	41,088	64,980
Lisa Patel	Nil-Cost Option	3,680	5,970
Liz Vaughan-Adams	Nil-Cost Option	38,272	52,664
Moray Wright	Nil-Cost Option	84,876	88,260
Dan Xie	Nil-Cost Option	29,790	44,874
Anthony York	Nil-Cost Option	33,498	33,498
Total		793,630	1,273,716

In addition to the above, awards over a total of 1,272,544 Shares were made to certain other of the Group's employees. As at the date of this announcement, a total of 3,377,871 nil-cost options over Shares remain outstanding under the IP Group DBSP. 

No consideration was paid for the grant of the awards and no consideration is due on the maturity of the option period. Fifty per cent of the options will normally be automatically exercised on 31 March 2023 and fifty per cent on 31 March 2024, with each such automatic exercise generally subject to continued employment.

Shares in issue

At the date of this announcement, the Company continues to have 1,063,033,287 Shares in issue and 28,938,473 Shares held in treasury.

The following information is being disclosed pursuant to the requirements of MAR.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

DBSP awards

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Greg Smith

David Baynes

Sam Williams

Mark Reilly

Angela Leach

Christopher Glasson

Lisa Patel

Liz Vaughan-Adams

Moray Wright

Dan Xie

Anthony York

2

Reason for the notification

a)

Position/status

Director        Chief Executive Officer

Director        Chief Operating and Financial Officer

PDMR          Managing Partner, Life Sciences

PDMR          Managing Partner, Technology

PDMR          General Counsel & Company Secretary

PDMR          Finance Director

PDMR          Partner, Employee Executive

PDMR          Director of Communications

PDMR          CEO Parkwalk

PDMR          Partner, Employee Executive

PDMR          Group People Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IP Group plc

b)

Legal Entity Identifier

213800HG22UM138WFG43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2p each in IP Group plc

ISIN: GB00B128J450

b)

Nature of the transaction

Grant of nil-cost options under the IP Group plc DBSP

c)

Currency

GBP

d)

Price(s) and volume(s)

Name(s)	Price(s)	Volume(s)
Greg Smith	Nil cost option	176,200
David Baynes	Nil cost option	150,902
Sam Williams	Nil cost option	82,364
Mark Reilly	Nil cost option	94,736
Angela Leach	Nil cost option	58,224
Christopher Glasson	Nil cost option	41,088
Lisa Patel	Nil cost option	3,680
Liz Vaughan-Adams	Nil cost option	38,272
Moray Wright	Nil cost option	84,876
Dan Xie	Nil cost option	29,790
Anthony York	Nil cost option	33,498

e)

Aggregated information

-Aggregated volume

- Price

- Aggregated total

Aggregated number of options granted under the DBSP to Directors and PDMRs on 21 April 2022: 793,630

Price: £ nil

f)

Date of the transaction

21 April 2022

g)

Place of the transaction

Outside a trading venue

For more information, please contact:

IP Group plc	www.ipgroupplc.com
Liz Vaughan-Adams, Communications	+44 (0) 20 7444 0062/+44 (0) 7979 853802
Charlotte Street Partners
David Gaffney	+44 (0) 7854 609998
Andrew Wilson	+44 (0) 7810 636995

Notes for editors

About IP Group

IP Group develops world-changing science and technology businesses across life sciences, technology and cleantech. The Group has a strong track record of success, having been the founder investor in a number of high-profile companies including Oxford Nanopore Technologies plc, and has one of the most exciting portfolios of high-growth businesses in Europe. The Group also owns Parkwalk, the UK's largest growth EIS fund manager which backs world-changing technologies emerging from the UK's leading universities and research institutions. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

For more information, please visit our website at www.ipgroupplc.com.

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHUVRBRUWUSUAR